Email Updates
Study
Medication errors during treatment with new oral anticancer agents: consequences for clinical practice based on the AMBORA Study.
November 3, 2021
Schlichtig K, Dürr P, Dörje F, et al. Clin Pharmacol Ther. 2021;110(4):1075-1086.
Building on prior research, this study found that medication errors are common in patients starting new oral anticancer therapy. Nearly two-thirds of these medication errors involved concomitantly administered medications (e.g., other prescribed drugs, over-the-counter medications).
Related Resources From the Same Author(s)
